Bitget App
Aqlliroq savdo qiling
Kripto sotib olishBozorlarSavdoFyuchersEarnKvadratKo'proq
Narx
Ma'lumot
Haqida
NTRA stock price forecast
Yangiliklar
Raqobatchilar
Tokenizatsiya
Kripto
Tez-tez beriladigan savollar
Natera, Inc. aksiyasi logotipi

Natera, Inc.

NTRA·NASDAQ

Oxirgi yangilanish: 2026-02-13 19:20 EST Aksiya narxlari haqidagi ma'lumotlar TradingView'dan olingan va real vaqt rejimidagi bozor narxlarini aks ettiradi.

Insaytlar
Kalkulyator
Yangiliklar

NTRA aksiya narxining o'zgarishi

Oxirgi savdo kunida, NTRA aksiya 207.84 USD narxda yopildi, kun uchun narx o'zgarishi -2.18%.
Aksiya fyucherslari savdosi

Bitget haqida

Dunyodagi birinchi universal birja (UEX) bo'lib, u foydalanuvchilarga nafaqat kriptovalyutalar, balki aksiyalar, ETF, valyutalar, oltin va real aktivlar (RWA) bilan ham savdo qilish imkonini beradi.
Batafsil

NTRA asosiy ma'lumotlari

Oldingi yopilish207.84 USD
Bozor qiymati28.75B USD
Hajm931.36K
P/E nisbati-
Dividend daromadi (TTM)0.00%
Dividend miqdori-
So'nggi dividend to'lash sanasi-
Oxirgi to'lov sanasi-
Suyultirilgan EPS (TTM)-2.28 USD
Sof daromad (FY)−190.43M USD
Daromad (FY)1.70B USD
Keyingi hisobot sanasiMar 4, 2026
EPS taxmini-
Taxminiy daromad604.04M USD USD
Savdodagi aksiyalar131.67M
Beta (1Y)0.90
Tokenized stocks

Tokenlashtirilgan aksiyalar haqida eshitganmisiz?

Aksiyalarda savdo qilishning yangi usuli – istalgan vaqtda, istalgan joyda, 24/7.

Batafsil

Natera, Inc. umumiy ko'rinish

Natera, Inc. — bu diagnostika kompaniyasi bo‘lib, genetik test xizmatlarini aniqlash, ishlab chiqish va tijoratlashtirish bilan shug‘ullanadi. Kompaniya Panorama invaziv bo‘lmagan prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening va spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) hamda invaziv bo‘lmagan otalik testlari (PAT)ni taqdim etadi. Kompaniya 2003-yil noyabr oyida Matthew Rabinowitz va Jonathan Sheena tomonidan tashkil etilgan va bosh ofisi Austin, TXda joylashgan.
Sektor
Sog‘liqni saqlash texnologiyasi
Sanoat
Biotexnologiya
CEO
Stephen Leonard Chapman
Bosh shtab
Austin
Veb-sayt
natera.com
Tashkil etilgan
2003
Xodimlar (FY)
4.43K
O'zgarish (1 yil)
+1.14K +34.65%
Daromad / Xodim (1Y)
382.70K USD
Sof daromad / Xodim (1Y)
−42.95K USD

NTRA impulsi

Daily updates on NTRA stock prices, fund flows, and market news, generated by AI and reviewed by our team of analysts. Always DYOR.

• NTRA aksiyalarining 24 soatlik narx o‘zgarishi: +0.38%. 211.65 AQSh dollaridan 212.46 AQSh dollarigacha o‘sdi.
• Texnik nuqtai nazardan, NTRA hozirda "qisqa muddatli tiklanish bosqichida": 50 kunlik harakatlanuvchi o‘rtacha ($231.82) joriy narxdan yuqorida bo‘lib, qarshilik sifatida harakat qilmoqda, biroq aksiyalar 200 kunlik harakatlanuvchi o‘rtacha ($198.09) dan ancha yuqorida, bu esa uzoq muddatli o‘sish tendensiyasi saqlanib qolganini ko‘rsatadi. O‘tgan haftada RSI 40 atrofida bo‘lgan haddan tashqari sotilgan holat aksiyalarda biroz tiklanishga sabab bo‘ldi, biroq harakatlanuvchi o‘rtachalar asosidagi kunlik "Kuchli sotish" signali, so‘nggi ichki sotuvlar fonida ehtiyotkorlikni tavsiya qiladi.
• Natera bosh direktori Stiven Chapman va moliya direktori Maykl Brofi fevral oyining boshida oldindan kelishilgan 10b5-1 rejalariga muvofiq jami 22 million dollarlik aksiyalarni sotib, narxlarning o‘zgaruvchanligiga va 9 kun ichida 15% pasayishiga sabab bo‘ldi.
• Kompaniya Signatera CDx testini mushaklarni zararlovchi pufakcha saratoni uchun yordamchi diagnostika sifatida FDAga Premarket Approval (PMA) arizasini topshirdi, bu onkologiya yo‘nalishidagi muhim bosqichdir.
• Natera 2025 yil 4-chorak uchun dastlabki daromad o‘sishi yiliga deyarli 40% bo‘lganini e’lon qildi, bu tahlilchilar kutganidan ancha yuqori va Piper Sandler hamda Morgan Stanley kabi yirik brokerlik kompaniyalaridan "Outperform" reytingini davom ettirishga sabab bo‘ldi.
• BridgeBio Pharma o‘zining axondroplaziya dori vositasi uchun muvaffaqiyatli 3-bosqich klinik sinov natijalarini e’lon qildi, Lundbeck esa migrenning oldini olish bo‘yicha ijobiy natijalarni bildirdi, bu esa biotexnologiya sohasida yuqori ta’sirli klinik ma’lumotlar chiqarilayotgan davrni ko‘rsatadi.
• Icon plc 2025 yilgi moliyaviy ko‘rsatkichlari bo‘yicha prognozini qaytarib oldi va ichki buxgalteriya tekshiruvini boshladi, bu esa tibbiy tadqiqot va klinik xizmatlar sohasida ehtiyotkorlik kayfiyatini kuchaytirdi.
Ko'proq ko'rish
taxm. 1 kun oldin
• NTRA aksiyalarining 24 soatlik narxi o‘zgarishi: -2.79%. 211.66 AQSh dollaridan 205.75 AQSh dollarigacha pasaydi. Ushbu pasayish asosan bosh direktor va boshqa rahbarlarning ichki aksiyalarini katta miqdorda sotishi hamda sog‘liqni saqlash diagnostika sektori bo‘yicha bozorning kengroq tahlili natijasida investorlarning davomli reaksiyasi bilan bog‘liq bo‘ldi.
• Texnik nuqtai nazardan, aksiyalar hozirda "uzoq muddatli o‘sish trendida qisqa muddatli pasayish fazasida". U 20 kunlik (231.27) va 50 kunlik (233.64) harakatlanuvchi o‘rtacha qiymatlardan pastda savdo qilinmoqda, biroq 200 kunlik harakatlanuvchi o‘rtacha qiymatdan (184.08) yuqorida qolmoqda. RSI 30 atrofida, bu esa aksiyaning haddan tashqari sotilgan hududga yaqinlashayotganini ko‘rsatadi va $200 darajasida texnik tiklanish ehtimolini oshiradi.
• Natera bosh direktori Stiven Leonard Chapman va boshqa insayderlar 2026 yil fevral oyi boshida oldindan belgilangan 10b5-1 savdo rejalari asosida jami 20 million dollardan ortiq aksiyalar sotganliklarini oshkor qilishdi.
• Natera Signatera CDx testi orqali pufakcha saratoni bemorlarida molekulyar qoldiq kasallikni (MRD) aniqlash uchun FDAga Premarket Approval (PMA) arizasini topshirganini e’lon qildi.
• Kompaniya yurak ko‘chirib o‘tkazilgan bemorlarda muntazam biopsiyalarga invaziv bo‘lmagan muqobil sifatida Prospera Heart testini baholash uchun ACES-EMB randomizatsiyalangan tadqiqotiga bemorlarni to‘liq jalb qilishni yakunladi.
• Buyuk Britaniya hukumati sog‘liqni saqlash tizimi bo‘ylab innovatsion saraton diagnostikasi va sun’iy intellekt vositalarini tezroq joriy etish uchun Milliy HealthTech Access Dasturini ishga tushirdi.
• Global raqamli diagnostika bozori prognozlariga ko‘ra, 2033 yilga kelib sun’iy intellekt integratsiyasi va aniq tibbiyotga bo‘lgan talabning oshishi natijasida 18.3% CAGR bilan 8.6 milliard dollarga yetishi kutilmoqda.
Ko'proq ko'rish
taxm. 2 kun oldin

NTRA stock price forecast

According to technical indicators for NTRA stock, the price is likely to fluctuate within the range of 245.77–253.88 USD over the next week. Market analysts predict that the price of NTRA stock will likely fluctuate within the range of 217.21–254.06 USD over the next months.

Based on 1-year price forecasts from 63 analysts, the highest estimate is 300.38 USD, while the lowest estimate is 209.67 USD.

For more information, please see the NTRA stock price forecast Stock Price Forecast page.

Bitget hisobi bilan siz bir vaqtning o'zida aksiyalar va kriptovalyutalar bilan savdo qilishingiz mumkin.

Hoziroq qo'shilish!

Tez-tez beriladigan savollar

Natera, Inc. aksiya narxi qancha?

NTRA joriy narxi 207.84 USD – uning narxi oxirgi 24 soat ichida -2.18% ga o'zgargan. Ushbu sahifaning yuqori qismidagi narxlar grafigida Natera, Inc. aksiyasi narxi ko'rsatkichlarini batafsilroq kuzatishingiz mumkin.

Natera, Inc. aksiya tikeri nima?

Birjaga ko'ra, aksiya tikeri farq qilishi mumkin. Masalan, NASDAQ, Natera, Inc. – NTRA tikeri bilan savdo qilinadi.

NTRA aksiya prognozi qancha?

Biz Natera, Inc.ning kelajakdagi narxi borasida tahlilchilar fikrlarini to'pladik. Ularning prognozlariga ko'ra, NTRAning maksimal bahosi 2078.35 USD va minimal bahosi 415.67 USD.

Natera, Inc. bozor qiymati qancha?

Natera, Inc. bozor kapitalizatsiyasi – 28.75B USD.

What is P/E ratio (TTM)?

The P/E ratio (TTM) stands for price-to-earnings ratio (trailing twelve months). It is a historical valuation metric calculated using a company's earnings per share (EPS) over the most recent twelve consecutive months, reflecting the company's past profitability.

The P/E ratio measures the relationship between a stock's price and a company's profitability, and is often used as a basis for judging whether a stock is "cheap" or "expensive."

P/E ratio = market price (P) ÷ earnings per share (EPS), or P/E ratio = total market capitalization ÷ net profit attributable to shareholders

The interpretation of the P/E ratio (TTM) should always be considered alongside other factors and is mainly used for valuation comparisons rather than as a standalone indicator.

  • A lower P/E ratio (TTM) means investors are paying less for each unit of earnings. This may indicate that the stock is undervalued, or that the market has limited expectations for the company's future growth, such as in mature or slow-growing industries.
  • A higher P/E ratio (TTM) means investors are paying more for each unit of earnings. This often reflects expectations of strong future earnings growth, which is common among growth or technology stocks, though it may also suggest the stock is overvalued.
  • Comparison with peers: Compare the company's P/E (TTM) with the average or median P/E of other companies in the same industry. A significantly higher P/E may require further analysis to determine whether the company's high valuation is justified by stronger growth prospects or competitive advantages.
  • Comparison with historical levels: Compare the company's current P/E (TTM) with its own historical average (such as over the past 5 or 10 years) to assess whether the current valuation is at a historical high or low.
  • Comparison with the broader market: Compare the company's P/E (TTM) with major market indices (such as the S&P 500) to see how the market is valuing the company overall.

P/E ratios can vary widely across industries, and there is no single "ideal" P/E level. A reasonable P/E range depends on the industry, the company's growth potential, and the broader macroeconomic environment. Investment decisions should not rely solely on the P/E ratio (TTM) but should be based on a comprehensive analysis that includes company quality, growth prospects, and financial health.

Can I trade stocks on Bitget?

You can trade stocks on Bitget, but mainly through stock tokens and stock perps, rather than by directly buying or selling traditional stocks.

This approach reflects Bitget's vision as a Universal Exchange (UEX), designed to connect traditional financial markets with cryptocurrency markets.

Bitget currently offers the following stock-related trading formats:

1. Stock tokens (spot)

Nature: Stock tokens are digital tokens pegged to the price of specific traditional stocks (such as TSLAUSDT and NVDAUSDT) and are traded on Bitget's spot market.

Features: When you trade stock tokens, you are buying and holding tokens rather than owning the underlying traditional stocks.

  • The price of these tokens generally follows the price movements of the stocks they are pegged to, such as Tesla or Nvidia.
  • The advantage is that you can participate in the price movements of traditional financial assets, such as U.S. stocks, using cryptocurrencies (for example, USDT), without the need for a traditional brokerage account.

2. Stock perps

Nature: Bitget also offers USDT-margined perpetual futures, commonly referred to as stock perps, based on major U.S. blue-chip stocks such as Tesla and Meta.

Characteristics: Stock perps are derivative products that allow you to take a bullish or bearish view on the future price of an underlying stock through margin trading. These products typically support leverage, such as up to 25x.

It does not involve owning the underlying stock. Instead, profits and losses are settled based on price movements of the futures.

Important note: When trading stock perps on Bitget, you are participating in derivative markets within the cryptocurrency ecosystem. This is fundamentally different from purchasing publicly traded shares through a traditional brokerage, as you do not own equity in the underlying company.

Futures trading and the use of leverage involve high risk. Please ensure you fully understand the risks before trading.

If you wish to directly hold equity in traditional stocks and enjoy shareholder rights (such as receiving dividends), you must trade through a regulated traditional securities brokerage or brokerage platform.

What are the advantages of Bitget's stock perps?

Bitget's stock perps—typically perpetual futures based on stock tokens prices—are an innovative offering that allows cryptocurrency platforms to provide exposure to traditional financial markets.

Compared to traditional stock or futures trading, they offer several unique advantages, primarily due to the platform's trading infrastructure.

Bitget's stock perps, typically USDT-denominated derivatives, offer the following key advantages:

1. Trading convenience and global accessibility

  • 24/7 trading: Traditional stock markets, such as U.S. equity markets, operate during fixed trading hours. In contrast, cryptocurrency derivatives markets are typically open 24/7. This means investors can trade anytime, capitalizing on breaking news or market fluctuations.
  • Lower entry barriers and faster onboarding: Compared with traditional brokerages, which often require extensive identity verification and lengthy account setup processes, Bitget generally offers faster account onboarding. Users can trade using cryptocurrencies such as USDT, without the need for complex fiat deposit and withdrawal procedures.
  • Global accessibility: Users can access derivatives trading linked to globally recognized stocks via the Bitget platform, subject to applicable regulations.

2. Capital efficiency and high leverage

  • High leverage options: Stock perps typically offer higher leverage than traditional stock trading (for example, up to 25x). This allows traders to control larger positions with smaller margin requirements, improving capital efficiency.
    Note: While high leverage can amplify gains, it also amplifies losses proportionally.
  • Two-way trading: Traders can easily take both long and short positions. This means traders can potentially profit from market volatility whether stock prices rise or fall, provided the market direction is correctly anticipated.

3. Trading and settlement using cryptocurrency

  • USDT margin: Stock perps on Bitget typically use USDT (or other stablecoins) as the margin and settlement currency. For users who already hold cryptocurrency, there is no need to convert assets into fiat currency, allowing them to trade directly with stablecoins.
  • Efficient fund transfers: Crypto-based transfers and settlements are typically faster than traditional fiat systems, enabling more efficient global fund allocation.

4. Integration

One-stop platform: Bitget allows users to trade spot cryptocurrencies, crypto derivatives, and stock perps on a single platform, making it easier to manage different asset types in one place.

Xavf haqida ogohlantirish:

While Bitget's stock perps offer several advantages, it is important to understand the associated risks.

  • High leverage risk: Leveraged trading can result in rapid loss of your entire margin.
  • No equity ownership: When trading stock perps, you do not own the underlying shares. As a result, you are not entitled to dividends or voting rights.
  • Market liquidity risk: Tokenized stock perps may have lower liquidity than their counterparts in traditional stock markets, especially outside regular trading hours.

In summary, Bitget's stock perps offer advantages such as greater trading flexibility, lower entry barriers, and higher capital efficiency.

What are the trading fees for Bitget stock perps?

Trading fees for Bitget stock perps (USDT-margined perpetual futures) mainly include transaction fees and funding rates.

Transaction fees:

Bitget offers limited-time fee promotions for stock perps (especially tokenized stock perps) from time to time to attract traders.

Standard reference rates: Under Bitget's standard futures fee structure, the taker fee is typically around 0.06%, while the maker fee is around 0.02%.

Current promotions for stock perps (important): To promote its stock perps products, Bitget is offering discounted transaction fees during Q4 2025, with taker fees as low as 0.006% and maker fees as low as 0.002%. There is also a limited-time promotion offering zero-fee trading for spot stock tokens.

Recommendation: Since promotional activities are subject to change or end at any time, please visit Bitget's official Fee overview or Announcement Center page for the latest and most accurate rates at the time of trading.

Funding rate:

The funding rate is a key mechanism in perpetual futures (including stock perps) that helps keep the futures price closely aligned with the spot price of the underlying asset. It is not a fee charged by the platform, but a periodic payment exchanged between long and short traders.

Funding rates fluctuate dynamically and are mainly driven by market sentiment and imbalances between long and short positions. Stock perps generally experience lower volatility than cryptocurrencies, so funding rates are often relatively low during stable market conditions. However, during earnings seasons or major positive or negative news events, heavy concentration of long or short positions—such as in high-growth technology stocks like Tesla or Nvidia—can create significant imbalances, causing funding rates to spike in the short term.

Funding payments are typically settled every 8 hours. If you close your position before the funding settlement time, no funding payment will be charged or received.

Funding rates are not fixed. If you hold a position for an extended period, high positive funding rates (for long positions) or high negative funding rates (for short positions) will affect your overall holding costs or potential returns. For this reason, it is important to monitor the funding rate in real time on the trading interface.